NCT05744414View on ClinicalTrials.gov

Histological Analysis of AlloMend® Acellular Dermal Matrix Used in Breast Implant Surgeries

Active, not recruitingOBSERVATIONAL

Enrollment

30

Participants

Timeline

Start Date

May 17, 2023

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions

Breast Implant; Complications, Infection or Inflammation

Trial Locations (1)

89521

Janiga MDs Plastic Surgery and Cosmetic Center, Reno

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AlloSource

INDUSTRY

NCT05744414 - Histological Analysis of AlloMend® Acellular Dermal Matrix Used in Breast Implant Surgeries | Biotech Hunter | Biotech Hunter